Genetics of Parkinson's disease and biochemical studies of implicated gene products

被引:70
作者
Lansbury, PT
Brice, A
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Cambridge, MA 02139 USA
[2] Harvard Univ, Sch Med, Dept Neurol, Cambridge, MA 02139 USA
[3] Grp Hosp Pitie Salpetriere, INSERM, U289, Dept Genet Cytogenet & Embryol, F-75013 Paris, France
关键词
D O I
10.1016/S0959-437X(02)00302-7
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Parkinson's disease was thought, until recently, to have little or no genetic component. This notion has changed with the identification of three genes, and the mapping of five others, that are linked to rare familial forms of the disease (FPD). The products of the identified genes, (x-synuclein (PARK 1), parkin (PARK 2), and ubiquitin-C-hydrolase-L1 (PARK 5) are the subject of intense cell-biological and biochemical studies designed to elucidate the underlying mechanism of FPD pathogenesis. In addition, the complex genetics of idiopathic PD is beginning to be unraveled. Genetic information may prove to be useful in identifying new therapeutic targets and identifying the preclinical phase of PD, allowing treatment to begin sooner.
引用
收藏
页码:299 / 306
页数:8
相关论文
共 83 条
[1]   Phenotypic characterisation of autosomal recessive PARK6-linked parkinsonism in three unrelated Italian families [J].
Bentivoglio, AR ;
Cortelli, P ;
Valente, EM ;
Ialongo, T ;
Ferraris, A ;
Elia, A ;
Montagna, P ;
Albanese, A .
MOVEMENT DISORDERS, 2001, 16 (06) :999-1006
[2]   Localization of autosomal recessive early-onset parkinsonism to chromosome 1p36 (PARK7) in an independent dataset [J].
Bonifati, V ;
Breedveld, GJ ;
Squitieri, F ;
Vanacore, N ;
Brustenghi, P ;
Harhangi, BS ;
Montagna, P ;
Cannella, M ;
Fabbrini, G ;
Rizzu, P ;
van Duijn, CM ;
Oostra, BA ;
Meco, G ;
Heutink, P .
ANNALS OF NEUROLOGY, 2002, 51 (02) :253-256
[3]   The parkin gene and its phenotype [J].
Bonifati, V ;
De Michele, G ;
Lücking, CB ;
Dürr, A ;
Fabrizio, E ;
Ambrosio, G ;
Vanacore, N ;
De Mari, M ;
Marconi, R ;
Capus, L ;
Breteler, MMB ;
Gasser, T ;
Oostra, B ;
Wood, N ;
Agid, Y ;
Filla, A ;
Meco, G ;
Brice, A .
NEUROLOGICAL SCIENCES, 2001, 22 (01) :51-52
[4]   Clinical features of parkinsonian patients with the α-synuclein (G209A) mutation [J].
Bostantjopoulou, S ;
Katsarou, Z ;
Papadimitriou, A ;
Veletza, V ;
Hatzigeorgiou, G ;
Lees, A .
MOVEMENT DISORDERS, 2001, 16 (06) :1007-1013
[5]   Diverse mutations in the gene for cartilage oligomeric matrix protein in the pseudoachondroplasia multiple epiphyseal dysplasia disease spectrum [J].
Briggs, MD ;
Mortier, GR ;
Cole, WG ;
King, LM ;
Golik, SS ;
Bonaventure, J ;
Nuytinck, L ;
De Paepe, A ;
Leroy, JG ;
Biesecker, L ;
Lipson, M ;
Wilcox, WR ;
Lachman, RS ;
Rimoin, DL ;
Knowlton, RG ;
Cohn, DH .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (02) :311-319
[6]   Lipid droplet binding and oligomerization properties of the Parkinson's disease protein α-synuclein [J].
Cole, NB ;
Murphy, DD ;
Grider, T ;
Rueter, S ;
Brasaemle, D ;
Nussbaum, RL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (08) :6344-6352
[7]   Cytosolic O-glycosylation is abundant in nerve terminals [J].
Cole, RN ;
Hart, GW .
JOURNAL OF NEUROCHEMISTRY, 2001, 79 (05) :1080-1089
[8]   Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease:: Implications for pathogenesis and therapy [J].
Conway, KA ;
Lee, SJ ;
Rochet, JC ;
Ding, TT ;
Williamson, RE ;
Lansbury, PT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (02) :571-576
[9]   Kinetic stabilization of the α-synuclein protofibril by a dopamine-α-synuclein adduct [J].
Conway, KA ;
Rochet, JC ;
Bieganski, RM ;
Lansbury, PT .
SCIENCE, 2001, 294 (5545) :1346-1349
[10]   Parkin and Parkinson's:: More than homonymy? [J].
Corti, O ;
Brice, A .
ANNALS OF NEUROLOGY, 2001, 50 (03) :283-285